160 related articles for article (PubMed ID: 8156973)
1. Clinical pharmacology and pharmacokinetics of oxcarbazepine.
Lloyd P; Flesch G; Dieterle W
Epilepsia; 1994; 35 Suppl 3():S10-3. PubMed ID: 8156973
[TBL] [Abstract][Full Text] [Related]
2. Oxcarbazepine: pharmacokinetic interactions and their clinical relevance.
Baruzzi A; Albani F; Riva R
Epilepsia; 1994; 35 Suppl 3():S14-9. PubMed ID: 8156974
[TBL] [Abstract][Full Text] [Related]
3. Oxcarbazepine: clinical development program.
Schwabe S
Epilepsia; 1994; 35 Suppl 5():S51-3. PubMed ID: 8039472
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of oxcarbazepine.
May TW; Korn-Merker E; Rambeck B
Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta.
Pienimäki P; Lampela E; Hakkola J; Arvela P; Raunio H; Vähäkangas K
Epilepsia; 1997 Mar; 38(3):309-16. PubMed ID: 9070593
[TBL] [Abstract][Full Text] [Related]
6. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine.
Isojärvi JI; Pakarinen AJ; Rautio A; Pelkonen O; Myllylä VV
Epilepsia; 1994; 35(6):1217-20. PubMed ID: 7988514
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic variability of oxcarbazepine in epileptic patients].
Viola MS; Bercellini MA; Saidón P; Rubio MC
Medicina (B Aires); 2000; 60(6):914-8. PubMed ID: 11436701
[TBL] [Abstract][Full Text] [Related]
8. Oxcarbazepine: mechanisms of action.
McLean MJ; Schmutz M; Wamil AW; Olpe HR; Portet C; Feldmann KF
Epilepsia; 1994; 35 Suppl 3():S5-9. PubMed ID: 8156978
[TBL] [Abstract][Full Text] [Related]
9. Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action.
Schmutz M; Brugger F; Gentsch C; McLean MJ; Olpe HR
Epilepsia; 1994; 35 Suppl 5():S47-50. PubMed ID: 8039471
[TBL] [Abstract][Full Text] [Related]
10. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy.
Isojärvi JI; Turkka J; Pakarinen AJ; Kotila M; Rättyä J; Myllylä VV
Epilepsia; 2001 Jul; 42(7):930-4. PubMed ID: 11488894
[TBL] [Abstract][Full Text] [Related]
11. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta.
Myllynen P; Pienimäki P; Raunio H; Vähäkangas K
Hum Exp Toxicol; 1998 Dec; 17(12):668-76. PubMed ID: 9988371
[TBL] [Abstract][Full Text] [Related]
12. Overview of the clinical pharmacokinetics of oxcarbazepine.
Flesch G
Clin Drug Investig; 2004; 24(4):185-203. PubMed ID: 17516704
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactive skin eruption with both carbamazepine and oxcarbazepine.
Beran RG
Epilepsia; 1993; 34(1):163-5. PubMed ID: 8422852
[TBL] [Abstract][Full Text] [Related]
14. Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women.
Fattore C; Cipolla G; Gatti G; Limido GL; Sturm Y; Bernasconi C; Perucca E
Epilepsia; 1999 Jun; 40(6):783-7. PubMed ID: 10368079
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19.
Lakehal F; Wurden CJ; Kalhorn TF; Levy RH
Epilepsy Res; 2002 Dec; 52(2):79-83. PubMed ID: 12458024
[TBL] [Abstract][Full Text] [Related]
16. Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients.
May TW; Rambeck B; Sälke-Kellermann A
Acta Neurol Scand; 1996 Jun; 93(6):393-7. PubMed ID: 8836299
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
Flesch G; Czendlik C; Renard D; Lloyd P
Drug Metab Dispos; 2011 Jun; 39(6):1103-10. PubMed ID: 21389120
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children.
Rodrigues C; Chiron C; Rey E; Dulac O; Comets E; Pons G; Jullien V
Br J Clin Pharmacol; 2017 Dec; 83(12):2695-2708. PubMed ID: 28771787
[TBL] [Abstract][Full Text] [Related]
19. Transplacental passage of oxcarbazepine and its metabolites in vivo.
Myllynen P; Pienimäki P; Jouppila P; Vähäkangas K
Epilepsia; 2001 Nov; 42(11):1482-5. PubMed ID: 11879354
[TBL] [Abstract][Full Text] [Related]
20. Dose dependent enzyme induction by oxcarbazepine?
Patsalos PN; Zakrzewska JM; Elyas AA
Eur J Clin Pharmacol; 1990; 39(2):187-8. PubMed ID: 2253672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
